Scientists Map the Structure of Immature Pig Islets—A Step Toward Better Transplant Sources
Researchers are studying young piglet pancreases to understand whether pig islet cells could one day help replace damaged insulin-producing cells in people with type 1 diabetes. A new study reveals that these immature islets have a surprisingly consistent and organized structure.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Pig islets from 14-day-old piglets contain well-developed insulin and glucagon-producing cells arranged in patterns similar to adult pig and human islets.
- The size and distribution of immature islet cell clusters are consistent across different piglets, suggesting predictable biology that could be useful for transplantation.
- Smaller islet clusters have a higher proportion of insulin-producing beta cells, while larger clusters contain more glucagon-producing alpha cells—a difference researchers are documenting for the first time.
- This foundational research does not yet demonstrate that pig islets work in people; it is an early step in understanding whether xenotransplantation could address the shortage of donor islets.
Why Pig Islets Matter for Type 1 Diabetes
One promising approach to treating type 1 diabetes is islet cell transplantation—transferring insulin-producing cells into people whose immune systems have destroyed their own. The challenge is a severe shortage of donor islets from human cadavers. Researchers are exploring whether islets from pigs (called xenotransplantation) could bridge that gap.
Young piglets are being studied as a potential source because their pancreases are easier to access and their islets may be less likely to trigger rejection. But before pig islets can be used clinically, scientists need to understand their structure and maturity.
What Researchers Found in Young Piglet Pancreases
A team of researchers examined pancreatic tissue from six 14-day-old piglets using specialized imaging techniques that highlighted insulin-producing beta cells and glucagon-producing alpha cells. They classified the islet cell clusters they found into three size categories: small (1–2 cells), intermediate (3–5 cells), and large (6 or more cells).
The most striking finding was that the largest clusters—measuring roughly 100 micrometers in diameter—resembled the structure of fully developed islets in adult pigs and humans. These larger clusters showed the same mixed arrangement of beta and alpha cells seen in mature islets, suggesting that even at this early postnatal stage, some islet structures are already well-organized.
Consistency Across Piglets Suggests Reliable Biology
When the researchers compared islet structure across all six piglets and even among littermates, they found the distribution of small, intermediate, and large clusters was remarkably consistent. This uniformity is important: it suggests that islet development in young piglets follows a predictable pattern, which could make them more reliable for transplantation purposes than using human donors.
The team also quantified the ratio of beta cells to alpha cells in each cluster size. In small and intermediate clusters, beta cells outnumbered alpha cells by roughly 3.7 and 3.8 to 1, respectively. In larger clusters, this ratio dropped to about 2.2 to 1, meaning the proportion of alpha cells increased in the largest islets.
What This Means for Future Research
This study is foundational work—it documents the structure and composition of immature pig islets in detail, creating a reference point for understanding whether they might eventually work in people. The consistency and organization observed in 14-day-old piglets suggest they may be a viable cell source worth further investigation.
However, showing that pig islets have the right structure is just one piece of a much larger puzzle. Researchers still need to test whether these islets can survive transplantation, function properly in a human environment, and avoid triggering immune rejection. Many years of additional research and clinical testing lie ahead before pig islet transplantation could become a treatment option for type 1 diabetes.
Evidence label
Source: Xenotransplantation. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Cure & AdvancementsGene-Edited Islets Show Promise, But Long-Term Questions RemainPubMed indexed literature
- Cure & AdvancementsStem Cell-Derived Islets: A New Research Path Toward Restoring Insulin ProductionPubMed indexed literature
- Cure & AdvancementsBerberine Shows Promise for Pancreatic Cell Recovery in Type 1 Diabetes ResearchPubMed indexed literature
- Cure & AdvancementsA Vitamin A Compound Shows Promise in Rodent Models of Type 1 DiabetesPubMed indexed literature
- Cure & AdvancementsHow Omega-3s May Help Reshape the Gut-Pancreas Connection in Type 1 DiabetesPubMed indexed literature
- Cure & AdvancementsNew Research Points to BCL6 as a Potential Target to Stop Type 1 Diabetes DevelopmentPubMed indexed literature